ROYALDERM Agnieszka Nawrocka
- Address
- ul. Krzysztofa Kieślowskiego 3B/3, 02-962 Warsaw, Poland
Immune System Diseases
The research at ROYALDERM Agnieszka Nawrocka concentrates on immune system diseases that affect the skin, especially chronic urticaria and its inducible forms. Studies are designed to compare new biologic agents with established therapies and to explore innovative treatment pathways for patients with inadequate response to antihistamines.
- Therapeutic equivalence investigations in chronic spontaneous urticaria
- Evaluation of novel BTK inhibitors for chronic inducible urticaria
- Safety and tolerability assessments of emerging biologics in urticaria
By focusing on these objectives, the site aims to broaden effective options for individuals living with chronic urticaria and improve overall disease management.
Skin and Connective Tissue Diseases
In the field of skin and connective tissue diseases, the centre targets moderate to severe plaque psoriasis, seeking to confirm long‑term safety and sustained efficacy of new therapeutic agents. The research emphasizes durability of response and integrates patient‑reported outcomes to enhance treatment relevance.
- Long‑term safety monitoring of innovative psoriasis biologics
- Assessment of durability of clinical response in plaque psoriasis
- Incorporation of quality‑of‑life measures in skin disease trials
Located in Warsaw, Poland, the facility leverages its expertise to advance therapeutic options for psoriasis patients and contribute to broader dermatologic care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novartis Pharma AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ROYALDERM Agnieszka Nawrocka
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicenter, randomized, double-blind, placebo-controlled, Phase II platform study to assess the efficacy and safety of investigational compound(s) in patients with moderate to severe atopic dermatitis | Novartis Pharma AG | Phase II | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dupilumab | 1 | Unknown | 2025-04-30 | 2025-04-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.